FEWER DEATHS OR HOSPITALIZATIONS FOR HEART FAILURE USING HYDRALAZINE-ISOSORBIDE MONONITRATE COMPARED TO HYDRALAZINE-ISOSORBIDE DINITRATE IN PATIENTS WITH SYSTOLIC HEART FAILURE

Hydralazine-isosorbide dinitrate (H-ISDN) carries an indication for treating systolic heart failure (HF). Hydralazine-isosorbide mononitrate (H-ISMN) does not carry this indication, but is used nonetheless as ISMN is once a day, while ISDN is three times a day. How effective H-ISMN is compared to H-